These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 12828075)
1. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis. Savas MC; Koruk M; Pirim I; Yilmaz O; Karakok M; Taysi S; Yilmaz A Hepatogastroenterology; 2003; 50(51):738-41. PubMed ID: 12828075 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis. Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532 [TBL] [Abstract][Full Text] [Related]
3. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis. Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008 [TBL] [Abstract][Full Text] [Related]
4. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270 [TBL] [Abstract][Full Text] [Related]
5. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180 [TBL] [Abstract][Full Text] [Related]
6. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis. Ito S; Yukawa T; Uetake S; Yamauchi M Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172 [TBL] [Abstract][Full Text] [Related]
7. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease]. Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885 [TBL] [Abstract][Full Text] [Related]
8. A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis. Başkol M; Başkol G; Deniz K; Ozbakir O; Yücesoy M Turk J Gastroenterol; 2005 Sep; 16(3):119-23. PubMed ID: 16245219 [TBL] [Abstract][Full Text] [Related]
9. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116 [TBL] [Abstract][Full Text] [Related]
11. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis. Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144 [TBL] [Abstract][Full Text] [Related]
12. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Fassio E; Alvarez E; Domínguez N; Landeira G; Longo C Hepatology; 2004 Oct; 40(4):820-6. PubMed ID: 15382171 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Wanless IR; Shiota K Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients. Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Koruk M; Taysi S; Savas MC; Yilmaz O; Akcay F; Karakok M Ann Clin Lab Sci; 2004; 34(1):57-62. PubMed ID: 15038668 [TBL] [Abstract][Full Text] [Related]
17. The risk factors of fibrosis in nonalcoholic steatohepatitis. Fierbinţeanu-Braticevici C; Bengus A; Neamţu M; Usvat R Rom J Intern Med; 2002; 40(1-4):81-8. PubMed ID: 15526543 [TBL] [Abstract][Full Text] [Related]
18. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. Spahr L; Rubbia-Brandt L; Hadengue A Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004 [TBL] [Abstract][Full Text] [Related]
19. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517 [TBL] [Abstract][Full Text] [Related]
20. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Palekar NA; Naus R; Larson SP; Ward J; Harrison SA Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]